CareDx Inc (NASDAQ: CDNA) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.62 versus a loss $-2.21 for the same period a year ago — a decline of -173%. For the latest four quarters through December 31, E.P.S. were $1.00 versus $-3.54 for the same period a year ago — a decline of -128%.
Recent Price Action
On 2/26/25, CareDx Inc (NASDAQ: CDNA) stock increased 1.0%, closing at $21.10. Trading volume in this advance was normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -13.8% during the last week.
Current PriceTarget Research Rating
CareDx has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock's attractiveness. CareDx has a poor Appreciation Score of 22 but a good Power Rating of 84, leading to the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.